nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—CYP2C18—Ifosfamide—testicular cancer	0.125	0.163	CbGbCtD
Phenytoin—SLCO1C1—Methotrexate—testicular cancer	0.0688	0.0899	CbGbCtD
Phenytoin—CYP3A7—Ifosfamide—testicular cancer	0.0416	0.0543	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.0416	0.0543	CbGbCtD
Phenytoin—CYP2B6—Ifosfamide—testicular cancer	0.0396	0.0517	CbGbCtD
Phenytoin—ABCC2—Carboplatin—testicular cancer	0.0354	0.0463	CbGbCtD
Phenytoin—ABCC2—Vinblastine—testicular cancer	0.033	0.0432	CbGbCtD
Phenytoin—CYP3A5—Ifosfamide—testicular cancer	0.0312	0.0407	CbGbCtD
Phenytoin—ABCC2—Cisplatin—testicular cancer	0.0303	0.0396	CbGbCtD
Phenytoin—CYP2C8—Ifosfamide—testicular cancer	0.03	0.0392	CbGbCtD
Phenytoin—ABCC2—Etoposide—testicular cancer	0.0297	0.0389	CbGbCtD
Phenytoin—CYP2C19—Ifosfamide—testicular cancer	0.0251	0.0329	CbGbCtD
Phenytoin—CYP2C9—Ifosfamide—testicular cancer	0.0209	0.0273	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—testicular cancer	0.0203	0.0265	CbGbCtD
Phenytoin—ABCC2—Methotrexate—testicular cancer	0.0196	0.0257	CbGbCtD
Phenytoin—CYP2B6—Cisplatin—testicular cancer	0.0192	0.0252	CbGbCtD
Phenytoin—ABCB1—Dactinomycin—testicular cancer	0.0172	0.0225	CbGbCtD
Phenytoin—CYP3A5—Etoposide—testicular cancer	0.0149	0.0195	CbGbCtD
Phenytoin—CYP2C8—Etoposide—testicular cancer	0.0143	0.0187	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—testicular cancer	0.0129	0.0169	CbGbCtD
Phenytoin—ALB—Methotrexate—testicular cancer	0.0122	0.016	CbGbCtD
Phenytoin—CYP3A4—Ifosfamide—testicular cancer	0.0122	0.0159	CbGbCtD
Phenytoin—ABCB1—Vinblastine—testicular cancer	0.0108	0.0141	CbGbCtD
Phenytoin—CYP2C9—Cisplatin—testicular cancer	0.0102	0.0133	CbGbCtD
Phenytoin—ABCB1—Cisplatin—testicular cancer	0.00987	0.0129	CbGbCtD
Phenytoin—ABCB1—Etoposide—testicular cancer	0.00969	0.0127	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—testicular cancer	0.00661	0.00864	CbGbCtD
Phenytoin—CYP3A4—Vinblastine—testicular cancer	0.00645	0.00843	CbGbCtD
Phenytoin—ABCB1—Methotrexate—testicular cancer	0.00641	0.00837	CbGbCtD
Phenytoin—CYP3A4—Etoposide—testicular cancer	0.00581	0.00759	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—testicular cancer	0.00396	0.00518	CbGbCtD
Phenytoin—Hyperglycaemia—Epirubicin—testicular cancer	0.000127	0.00054	CcSEcCtD
Phenytoin—Somnolence—Etoposide—testicular cancer	0.000127	0.000539	CcSEcCtD
Phenytoin—Hepatobiliary disease—Methotrexate—testicular cancer	0.000127	0.000539	CcSEcCtD
Phenytoin—Epistaxis—Methotrexate—testicular cancer	0.000126	0.000538	CcSEcCtD
Phenytoin—Pneumonia—Epirubicin—testicular cancer	0.000126	0.000536	CcSEcCtD
Phenytoin—Nausea—Bleomycin—testicular cancer	0.000126	0.000534	CcSEcCtD
Phenytoin—Drowsiness—Epirubicin—testicular cancer	0.000125	0.000533	CcSEcCtD
Phenytoin—Vomiting—Dactinomycin—testicular cancer	0.000125	0.000533	CcSEcCtD
Phenytoin—Bronchitis—Doxorubicin—testicular cancer	0.000125	0.000532	CcSEcCtD
Phenytoin—Agranulocytosis—Methotrexate—testicular cancer	0.000125	0.000532	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000124	0.000529	CcSEcCtD
Phenytoin—Rash—Dactinomycin—testicular cancer	0.000124	0.000529	CcSEcCtD
Phenytoin—Decreased appetite—Etoposide—testicular cancer	0.000124	0.000528	CcSEcCtD
Phenytoin—Diarrhoea—Ifosfamide—testicular cancer	0.000124	0.000526	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—testicular cancer	0.000124	0.000526	CcSEcCtD
Phenytoin—Renal failure—Epirubicin—testicular cancer	0.000123	0.000524	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Etoposide—testicular cancer	0.000123	0.000524	CcSEcCtD
Phenytoin—Body temperature increased—Cisplatin—testicular cancer	0.000123	0.000524	CcSEcCtD
Phenytoin—Fatigue—Etoposide—testicular cancer	0.000123	0.000523	CcSEcCtD
Phenytoin—Constipation—Etoposide—testicular cancer	0.000122	0.000519	CcSEcCtD
Phenytoin—Conjunctivitis—Epirubicin—testicular cancer	0.000122	0.000518	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—testicular cancer	0.000122	0.000518	CcSEcCtD
Phenytoin—Haemoglobin—Methotrexate—testicular cancer	0.000121	0.000514	CcSEcCtD
Phenytoin—Haemorrhage—Methotrexate—testicular cancer	0.00012	0.000512	CcSEcCtD
Phenytoin—Sweating—Epirubicin—testicular cancer	0.00012	0.000511	CcSEcCtD
Phenytoin—Dizziness—Ifosfamide—testicular cancer	0.000119	0.000508	CcSEcCtD
Phenytoin—Pharyngitis—Methotrexate—testicular cancer	0.000119	0.000508	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000119	0.000505	CcSEcCtD
Phenytoin—Hepatobiliary disease—Epirubicin—testicular cancer	0.000119	0.000504	CcSEcCtD
Phenytoin—Epistaxis—Epirubicin—testicular cancer	0.000118	0.000503	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—testicular cancer	0.000118	0.000501	CcSEcCtD
Phenytoin—Sinusitis—Epirubicin—testicular cancer	0.000118	0.0005	CcSEcCtD
Phenytoin—Feeling abnormal—Etoposide—testicular cancer	0.000118	0.0005	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—testicular cancer	0.000117	0.000499	CcSEcCtD
Phenytoin—Nausea—Dactinomycin—testicular cancer	0.000117	0.000498	CcSEcCtD
Phenytoin—Agranulocytosis—Epirubicin—testicular cancer	0.000117	0.000498	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—testicular cancer	0.000117	0.000496	CcSEcCtD
Phenytoin—Drowsiness—Doxorubicin—testicular cancer	0.000116	0.000494	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000115	0.000489	CcSEcCtD
Phenytoin—Vomiting—Ifosfamide—testicular cancer	0.000115	0.000489	CcSEcCtD
Phenytoin—Hypersensitivity—Cisplatin—testicular cancer	0.000115	0.000488	CcSEcCtD
Phenytoin—Bradycardia—Epirubicin—testicular cancer	0.000115	0.000487	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—testicular cancer	0.000114	0.000485	CcSEcCtD
Phenytoin—Rash—Ifosfamide—testicular cancer	0.000114	0.000484	CcSEcCtD
Phenytoin—Dermatitis—Ifosfamide—testicular cancer	0.000114	0.000484	CcSEcCtD
Phenytoin—Erythema multiforme—Methotrexate—testicular cancer	0.000114	0.000484	CcSEcCtD
Phenytoin—Urticaria—Etoposide—testicular cancer	0.000113	0.000482	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—testicular cancer	0.000113	0.000481	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—testicular cancer	0.000113	0.00048	CcSEcCtD
Phenytoin—Body temperature increased—Etoposide—testicular cancer	0.000113	0.00048	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—testicular cancer	0.000113	0.00048	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—testicular cancer	0.000113	0.000479	CcSEcCtD
Phenytoin—Tinnitus—Methotrexate—testicular cancer	0.000112	0.000477	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—testicular cancer	0.000112	0.000476	CcSEcCtD
Phenytoin—Asthenia—Cisplatin—testicular cancer	0.000112	0.000475	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—testicular cancer	0.000112	0.000475	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—testicular cancer	0.000111	0.000473	CcSEcCtD
Phenytoin—Connective tissue disorder—Epirubicin—testicular cancer	0.000111	0.000471	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.00011	0.000467	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—testicular cancer	0.000109	0.000465	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—testicular cancer	0.000109	0.000463	CcSEcCtD
Phenytoin—Immune system disorder—Methotrexate—testicular cancer	0.000109	0.000462	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—testicular cancer	0.000108	0.000461	CcSEcCtD
Phenytoin—Chills—Methotrexate—testicular cancer	0.000108	0.000459	CcSEcCtD
Phenytoin—Nausea—Ifosfamide—testicular cancer	0.000107	0.000456	CcSEcCtD
Phenytoin—Diarrhoea—Cisplatin—testicular cancer	0.000107	0.000453	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—testicular cancer	0.000106	0.000453	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—testicular cancer	0.000106	0.000451	CcSEcCtD
Phenytoin—Hypersensitivity—Etoposide—testicular cancer	0.000105	0.000447	CcSEcCtD
Phenytoin—Tinnitus—Epirubicin—testicular cancer	0.000105	0.000446	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—testicular cancer	0.000105	0.000445	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—testicular cancer	0.000104	0.000444	CcSEcCtD
Phenytoin—Haemorrhage—Doxorubicin—testicular cancer	0.000104	0.000443	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—testicular cancer	0.000104	0.000441	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—testicular cancer	0.000103	0.00044	CcSEcCtD
Phenytoin—Dysgeusia—Methotrexate—testicular cancer	0.000103	0.000436	CcSEcCtD
Phenytoin—Asthenia—Etoposide—testicular cancer	0.000102	0.000435	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000102	0.000435	CcSEcCtD
Phenytoin—Immune system disorder—Epirubicin—testicular cancer	0.000102	0.000432	CcSEcCtD
Phenytoin—Back pain—Methotrexate—testicular cancer	0.000101	0.000431	CcSEcCtD
Phenytoin—Chills—Epirubicin—testicular cancer	0.000101	0.00043	CcSEcCtD
Phenytoin—Pruritus—Etoposide—testicular cancer	0.000101	0.000429	CcSEcCtD
Phenytoin—Vomiting—Cisplatin—testicular cancer	9.9e-05	0.000421	CcSEcCtD
Phenytoin—Erythema multiforme—Doxorubicin—testicular cancer	9.85e-05	0.000419	CcSEcCtD
Phenytoin—Rash—Cisplatin—testicular cancer	9.82e-05	0.000418	CcSEcCtD
Phenytoin—Dermatitis—Cisplatin—testicular cancer	9.81e-05	0.000417	CcSEcCtD
Phenytoin—Diarrhoea—Etoposide—testicular cancer	9.76e-05	0.000415	CcSEcCtD
Phenytoin—Ill-defined disorder—Methotrexate—testicular cancer	9.71e-05	0.000413	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—testicular cancer	9.71e-05	0.000413	CcSEcCtD
Phenytoin—Anaemia—Methotrexate—testicular cancer	9.68e-05	0.000412	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—testicular cancer	9.65e-05	0.000411	CcSEcCtD
Phenytoin—Tension—Epirubicin—testicular cancer	9.61e-05	0.000409	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—testicular cancer	9.6e-05	0.000408	CcSEcCtD
Phenytoin—Nervousness—Epirubicin—testicular cancer	9.52e-05	0.000405	CcSEcCtD
Phenytoin—Back pain—Epirubicin—testicular cancer	9.48e-05	0.000403	CcSEcCtD
Phenytoin—Malaise—Methotrexate—testicular cancer	9.44e-05	0.000402	CcSEcCtD
Phenytoin—Dizziness—Etoposide—testicular cancer	9.43e-05	0.000401	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—testicular cancer	9.42e-05	0.000401	CcSEcCtD
Phenytoin—Immune system disorder—Doxorubicin—testicular cancer	9.41e-05	0.0004	CcSEcCtD
Phenytoin—Vertigo—Methotrexate—testicular cancer	9.41e-05	0.0004	CcSEcCtD
Phenytoin—Leukopenia—Methotrexate—testicular cancer	9.37e-05	0.000399	CcSEcCtD
Phenytoin—Chills—Doxorubicin—testicular cancer	9.34e-05	0.000398	CcSEcCtD
Phenytoin—Nausea—Cisplatin—testicular cancer	9.25e-05	0.000393	CcSEcCtD
Phenytoin—Cough—Methotrexate—testicular cancer	9.14e-05	0.000389	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—testicular cancer	9.09e-05	0.000387	CcSEcCtD
Phenytoin—Convulsion—Methotrexate—testicular cancer	9.07e-05	0.000386	CcSEcCtD
Phenytoin—Vomiting—Etoposide—testicular cancer	9.07e-05	0.000386	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—testicular cancer	9.06e-05	0.000385	CcSEcCtD
Phenytoin—Agitation—Epirubicin—testicular cancer	9e-05	0.000383	CcSEcCtD
Phenytoin—Rash—Etoposide—testicular cancer	8.99e-05	0.000383	CcSEcCtD
Phenytoin—Dermatitis—Etoposide—testicular cancer	8.99e-05	0.000382	CcSEcCtD
Phenytoin—Headache—Etoposide—testicular cancer	8.94e-05	0.00038	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—testicular cancer	8.93e-05	0.00038	CcSEcCtD
Phenytoin—Arthralgia—Methotrexate—testicular cancer	8.91e-05	0.000379	CcSEcCtD
Phenytoin—Chest pain—Methotrexate—testicular cancer	8.91e-05	0.000379	CcSEcCtD
Phenytoin—Myalgia—Methotrexate—testicular cancer	8.91e-05	0.000379	CcSEcCtD
Phenytoin—Tension—Doxorubicin—testicular cancer	8.9e-05	0.000378	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—testicular cancer	8.88e-05	0.000378	CcSEcCtD
Phenytoin—Malaise—Epirubicin—testicular cancer	8.84e-05	0.000376	CcSEcCtD
Phenytoin—Discomfort—Methotrexate—testicular cancer	8.81e-05	0.000375	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—testicular cancer	8.81e-05	0.000375	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—testicular cancer	8.8e-05	0.000374	CcSEcCtD
Phenytoin—Syncope—Epirubicin—testicular cancer	8.79e-05	0.000374	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—testicular cancer	8.77e-05	0.000373	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—testicular cancer	8.77e-05	0.000373	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—testicular cancer	8.72e-05	0.000371	CcSEcCtD
Phenytoin—Palpitations—Epirubicin—testicular cancer	8.66e-05	0.000368	CcSEcCtD
Phenytoin—Confusional state—Methotrexate—testicular cancer	8.62e-05	0.000367	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—testicular cancer	8.61e-05	0.000366	CcSEcCtD
Phenytoin—Cough—Epirubicin—testicular cancer	8.55e-05	0.000364	CcSEcCtD
Phenytoin—Anaphylactic shock—Methotrexate—testicular cancer	8.54e-05	0.000363	CcSEcCtD
Phenytoin—Convulsion—Epirubicin—testicular cancer	8.49e-05	0.000361	CcSEcCtD
Phenytoin—Infection—Methotrexate—testicular cancer	8.49e-05	0.000361	CcSEcCtD
Phenytoin—Nausea—Etoposide—testicular cancer	8.47e-05	0.00036	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—testicular cancer	8.46e-05	0.00036	CcSEcCtD
Phenytoin—Ill-defined disorder—Doxorubicin—testicular cancer	8.41e-05	0.000358	CcSEcCtD
Phenytoin—Nervous system disorder—Methotrexate—testicular cancer	8.38e-05	0.000356	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—testicular cancer	8.38e-05	0.000356	CcSEcCtD
Phenytoin—Thrombocytopenia—Methotrexate—testicular cancer	8.37e-05	0.000356	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—testicular cancer	8.34e-05	0.000355	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—testicular cancer	8.34e-05	0.000355	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—testicular cancer	8.34e-05	0.000355	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—testicular cancer	8.33e-05	0.000354	CcSEcCtD
Phenytoin—Hyperhidrosis—Methotrexate—testicular cancer	8.26e-05	0.000351	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—testicular cancer	8.24e-05	0.000351	CcSEcCtD
Phenytoin—Malaise—Doxorubicin—testicular cancer	8.18e-05	0.000348	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—testicular cancer	8.16e-05	0.000347	CcSEcCtD
Phenytoin—Vertigo—Doxorubicin—testicular cancer	8.15e-05	0.000346	CcSEcCtD
Phenytoin—Anorexia—Methotrexate—testicular cancer	8.15e-05	0.000346	CcSEcCtD
Phenytoin—Syncope—Doxorubicin—testicular cancer	8.13e-05	0.000346	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—testicular cancer	8.12e-05	0.000345	CcSEcCtD
Phenytoin—Confusional state—Epirubicin—testicular cancer	8.06e-05	0.000343	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—testicular cancer	8.01e-05	0.000341	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—testicular cancer	8e-05	0.00034	CcSEcCtD
Phenytoin—Hypotension—Methotrexate—testicular cancer	7.98e-05	0.00034	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—testicular cancer	7.97e-05	0.000339	CcSEcCtD
Phenytoin—Infection—Epirubicin—testicular cancer	7.94e-05	0.000338	CcSEcCtD
Phenytoin—Cough—Doxorubicin—testicular cancer	7.91e-05	0.000337	CcSEcCtD
Phenytoin—Shock—Epirubicin—testicular cancer	7.87e-05	0.000335	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—testicular cancer	7.86e-05	0.000334	CcSEcCtD
Phenytoin—Nervous system disorder—Epirubicin—testicular cancer	7.84e-05	0.000334	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—testicular cancer	7.83e-05	0.000333	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—testicular cancer	7.83e-05	0.000333	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—testicular cancer	7.8e-05	0.000332	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Methotrexate—testicular cancer	7.79e-05	0.000331	CcSEcCtD
Phenytoin—Hyperhidrosis—Epirubicin—testicular cancer	7.73e-05	0.000329	CcSEcCtD
Phenytoin—Insomnia—Methotrexate—testicular cancer	7.73e-05	0.000329	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—testicular cancer	7.72e-05	0.000328	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—testicular cancer	7.72e-05	0.000328	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—testicular cancer	7.72e-05	0.000328	CcSEcCtD
Phenytoin—Paraesthesia—Methotrexate—testicular cancer	7.67e-05	0.000326	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—testicular cancer	7.63e-05	0.000324	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—testicular cancer	7.62e-05	0.000324	CcSEcCtD
Phenytoin—Dyspnoea—Methotrexate—testicular cancer	7.62e-05	0.000324	CcSEcCtD
Phenytoin—Somnolence—Methotrexate—testicular cancer	7.6e-05	0.000323	CcSEcCtD
Phenytoin—Dry mouth—Doxorubicin—testicular cancer	7.55e-05	0.000321	CcSEcCtD
Phenytoin—Dyspepsia—Methotrexate—testicular cancer	7.52e-05	0.00032	CcSEcCtD
Phenytoin—Hypotension—Epirubicin—testicular cancer	7.47e-05	0.000318	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—testicular cancer	7.46e-05	0.000317	CcSEcCtD
Phenytoin—Decreased appetite—Methotrexate—testicular cancer	7.43e-05	0.000316	CcSEcCtD
Phenytoin—Anaphylactic shock—Doxorubicin—testicular cancer	7.4e-05	0.000315	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Methotrexate—testicular cancer	7.38e-05	0.000314	CcSEcCtD
Phenytoin—Fatigue—Methotrexate—testicular cancer	7.37e-05	0.000313	CcSEcCtD
Phenytoin—Infection—Doxorubicin—testicular cancer	7.35e-05	0.000313	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Epirubicin—testicular cancer	7.29e-05	0.00031	CcSEcCtD
Phenytoin—Shock—Doxorubicin—testicular cancer	7.28e-05	0.00031	CcSEcCtD
Phenytoin—Nervous system disorder—Doxorubicin—testicular cancer	7.26e-05	0.000309	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—testicular cancer	7.24e-05	0.000308	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—testicular cancer	7.23e-05	0.000308	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—testicular cancer	7.22e-05	0.000307	CcSEcCtD
Phenytoin—Paraesthesia—Epirubicin—testicular cancer	7.18e-05	0.000305	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—testicular cancer	7.15e-05	0.000304	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—testicular cancer	7.13e-05	0.000303	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—testicular cancer	7.11e-05	0.000302	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—testicular cancer	7.05e-05	0.0003	CcSEcCtD
Phenytoin—Feeling abnormal—Methotrexate—testicular cancer	7.04e-05	0.0003	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—testicular cancer	7.04e-05	0.000299	CcSEcCtD
Phenytoin—Decreased appetite—Epirubicin—testicular cancer	6.95e-05	0.000296	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—testicular cancer	6.91e-05	0.000294	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—testicular cancer	6.9e-05	0.000294	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—testicular cancer	6.89e-05	0.000293	CcSEcCtD
Phenytoin—Constipation—Epirubicin—testicular cancer	6.84e-05	0.000291	CcSEcCtD
Phenytoin—Urticaria—Methotrexate—testicular cancer	6.79e-05	0.000289	CcSEcCtD
Phenytoin—Body temperature increased—Methotrexate—testicular cancer	6.75e-05	0.000287	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	6.74e-05	0.000287	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—testicular cancer	6.69e-05	0.000285	CcSEcCtD
Phenytoin—Paraesthesia—Doxorubicin—testicular cancer	6.64e-05	0.000283	CcSEcCtD
Phenytoin—Dyspnoea—Doxorubicin—testicular cancer	6.6e-05	0.000281	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—testicular cancer	6.59e-05	0.00028	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—testicular cancer	6.58e-05	0.00028	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—testicular cancer	6.51e-05	0.000277	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—testicular cancer	6.43e-05	0.000274	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Doxorubicin—testicular cancer	6.39e-05	0.000272	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—testicular cancer	6.38e-05	0.000271	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—testicular cancer	6.35e-05	0.00027	CcSEcCtD
Phenytoin—Constipation—Doxorubicin—testicular cancer	6.33e-05	0.000269	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—testicular cancer	6.32e-05	0.000269	CcSEcCtD
Phenytoin—Hypersensitivity—Methotrexate—testicular cancer	6.3e-05	0.000268	CcSEcCtD
Phenytoin—Asthenia—Methotrexate—testicular cancer	6.13e-05	0.000261	CcSEcCtD
Phenytoin—Feeling abnormal—Doxorubicin—testicular cancer	6.1e-05	0.000259	CcSEcCtD
Phenytoin—Pruritus—Methotrexate—testicular cancer	6.05e-05	0.000257	CcSEcCtD
Phenytoin—Hypersensitivity—Epirubicin—testicular cancer	5.89e-05	0.000251	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—testicular cancer	5.88e-05	0.00025	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—testicular cancer	5.85e-05	0.000249	CcSEcCtD
Phenytoin—Diarrhoea—Methotrexate—testicular cancer	5.85e-05	0.000249	CcSEcCtD
Phenytoin—Asthenia—Epirubicin—testicular cancer	5.74e-05	0.000244	CcSEcCtD
Phenytoin—Pruritus—Epirubicin—testicular cancer	5.66e-05	0.000241	CcSEcCtD
Phenytoin—Dizziness—Methotrexate—testicular cancer	5.65e-05	0.00024	CcSEcCtD
Phenytoin—Diarrhoea—Epirubicin—testicular cancer	5.47e-05	0.000233	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—testicular cancer	5.45e-05	0.000232	CcSEcCtD
Phenytoin—Vomiting—Methotrexate—testicular cancer	5.43e-05	0.000231	CcSEcCtD
Phenytoin—Rash—Methotrexate—testicular cancer	5.39e-05	0.000229	CcSEcCtD
Phenytoin—Dermatitis—Methotrexate—testicular cancer	5.38e-05	0.000229	CcSEcCtD
Phenytoin—Headache—Methotrexate—testicular cancer	5.35e-05	0.000228	CcSEcCtD
Phenytoin—Asthenia—Doxorubicin—testicular cancer	5.31e-05	0.000226	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—testicular cancer	5.29e-05	0.000225	CcSEcCtD
Phenytoin—Pruritus—Doxorubicin—testicular cancer	5.23e-05	0.000223	CcSEcCtD
Phenytoin—Vomiting—Epirubicin—testicular cancer	5.08e-05	0.000216	CcSEcCtD
Phenytoin—Nausea—Methotrexate—testicular cancer	5.08e-05	0.000216	CcSEcCtD
Phenytoin—Diarrhoea—Doxorubicin—testicular cancer	5.06e-05	0.000215	CcSEcCtD
Phenytoin—Rash—Epirubicin—testicular cancer	5.04e-05	0.000214	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—testicular cancer	5.04e-05	0.000214	CcSEcCtD
Phenytoin—Headache—Epirubicin—testicular cancer	5.01e-05	0.000213	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—testicular cancer	4.89e-05	0.000208	CcSEcCtD
Phenytoin—Nausea—Epirubicin—testicular cancer	4.75e-05	0.000202	CcSEcCtD
Phenytoin—Vomiting—Doxorubicin—testicular cancer	4.7e-05	0.0002	CcSEcCtD
Phenytoin—Rash—Doxorubicin—testicular cancer	4.67e-05	0.000198	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—testicular cancer	4.66e-05	0.000198	CcSEcCtD
Phenytoin—Headache—Doxorubicin—testicular cancer	4.64e-05	0.000197	CcSEcCtD
Phenytoin—Nausea—Doxorubicin—testicular cancer	4.39e-05	0.000187	CcSEcCtD
